BrainQ
BrainQ is a pioneering company in brain longevity therapeutics, focusing on innovative solutions for stroke recovery and neurological disorders. They develop AI-powered, non-invasive, portable therapies designed to reduce disability and enhance neurorecovery, with a strong emphasis on personalized, home-based treatment options. Recognized for their groundbreaking technology, BrainQ aims to transform stroke care and improve patient outcomes through advanced bioelectric and AI-driven therapies.
Industries
Nr. of Employees
small (1-50)
Patents
System and method for generating electromagnetic treatment protocols for the nervous system
US-11559697-B2
View DetailsSystem and method for generating electromagnetic treatment protocols for the nervous system
US-10322295-B2
View Details
System and method for generating electromagnetic treatment protocols for the nervous system
US-11559697-B2
View DetailsSystem and method for generating electromagnetic treatment protocols for the nervous system
US-10322295-B2
View DetailsProducts
Wearable low-intensity electromagnetic neuromodulation system with virtual care integration
Investigational portable wearable system that delivers tailored, frequency-tuned, low-intensity electromagnetic field therapy paired with a cloud-based virtual care platform for remote session delivery, data telemetry, and clinician management.
Wearable low-intensity electromagnetic neuromodulation system with virtual care integration
Investigational portable wearable system that delivers tailored, frequency-tuned, low-intensity electromagnetic field therapy paired with a cloud-based virtual care platform for remote session delivery, data telemetry, and clinician management.
Services
Delivery of structured home rehabilitation via an app-based virtual care platform with caregiver education, guided exercises, and periodic virtual therapist check-ins.
Cloud-enabled monitoring, automated data upload, and clinician dashboard capabilities to manage patient sessions and progress remotely.
Design and operational support for randomized controlled and multicenter pivotal trials evaluating non-invasive neuromodulation therapies for stroke recovery, including endpoint selection and safety monitoring.
Advisory and operational support for pursuing expedited regulatory pathways and engaging with regulatory agencies during device development and clinical evaluation.
Delivery of structured home rehabilitation via an app-based virtual care platform with caregiver education, guided exercises, and periodic virtual therapist check-ins.
Cloud-enabled monitoring, automated data upload, and clinician dashboard capabilities to manage patient sessions and progress remotely.
Design and operational support for randomized controlled and multicenter pivotal trials evaluating non-invasive neuromodulation therapies for stroke recovery, including endpoint selection and safety monitoring.
Advisory and operational support for pursuing expedited regulatory pathways and engaging with regulatory agencies during device development and clinical evaluation.
Expertise Areas
- Stroke rehabilitation
- Non-invasive neuromodulation and electromagnetic therapies
- Passive brain–computer interface applications in neurorehabilitation
- AI-driven therapy personalization and neural signal analytics
Key Technologies
- Electroencephalography (EEG) signal analysis
- Passive brain–computer interfaces (passive BCI)
- Machine learning / explainable AI for neurophysiology
- Extremely-low-frequency electromagnetic field (ELF-EMF) stimulation
News & Updates
Recognition for their innovative contributions to healthcare technology.
Funding round led by Hanaco Ventures to support multicenter pivotal trial and infrastructure development.
Announcement of the start of a clinical trial for BrainQ’s innovative stroke therapy.
Results from a randomized controlled trial showing significant improvements in stroke recovery.
Recognition for innovative therapeutic solutions in healthcare technology.
Recognition for their innovative contributions to healthcare technology.
Funding round led by Hanaco Ventures to support multicenter pivotal trial and infrastructure development.
Announcement of the start of a clinical trial for BrainQ’s innovative stroke therapy.
Results from a randomized controlled trial showing significant improvements in stroke recovery.
Recognition for innovative therapeutic solutions in healthcare technology.